Martelli, Alberto Maria
Martelli, Alberto Maria
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
2024 Cervello, Melchiorre; Augello, Giuseppa; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y.; Martelli, Alberto M.; Cusimano, Antonella; Montalto, Giuseppe; Mccubrey, James A.
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy
2016 Candido, S; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Fitzgerald, Tl; Martelli, Am; Cocco, L; Montalto, G; Cervello, M; Polesel, J; Libra, M; Mccubrey, Ja
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment
2013 Chappell, Wh; Abrams, Sl; Stadelman, Km; Lahair, Mm; Franklin, Ra; Cocco, L; Evangelisti, C; Chiarini, F; Martelli, Am; Steelman, Ls; Mccubrey, Ja
The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy
2013 Simioni, C; Martelli, Am; Cani, A; Cetinatalay, R; Mccubrey, Ja; Capitani, S; Neri, Lm
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
2012 Follo, My; Mongiorgi, S; Clissa, C; Paolini, S; Martinelli, G; Martelli, Am; Fioravanti, G; Manzoli, L; Finelli, C; Cocco, L
Activity of the selective I?B kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a.
2012 Buontempo F; Chiarini F; Bressanin D; Tabellini G; Melchionda F; Pession A; Fini M; Neri LM; McCubrey JA; Martelli AM.
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
2012 Grimaldi C; Chiarini F; Tabellini G; Ricci F; Tazzari PL; Battistelli M; Falcieri E; Bortul R; Melchionda F; Iacobucci I; Pagliaro P; Martinelli G; Pession A; Barata JT; McCubrey JA; Martelli AM.
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.
2012 Simioni, C; Neri, Lm; Tabellini, G; Ricci, F; Bressanin, D; Chiarini, F; Evangelisti, C; Cani, A; Tazzari, Pl; Melchionda, F; Pagliaro, P; Pession, A; Mccubrey, Ja; Capitani, S; Martelli, Am
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.
2012 Chappell, Wh; Abrams, Sl; Franklin, Ra; Lahair, Mm; Montalto, G; Cervello, M; Martelli, Am; Nicoletti, F; Candido, S; Libra, M; Polesel, J; Talamini, R; Milella, M; Tafuri, A; Steelman, Ls; Mccubrey, Ja
Effects of ectopic expression of NGAL on doxorubicin sensitivity
2012 Chappell, Wh; Abrams, Sl; Montalto, G; Cervello, M; Martelli, Am; Candido, S; Libra, M; Polesel, J; Talamini, R; Arlinghaus, R; Steelman, Ls; Mccubrey, Ja
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels.
2012 Bressanin, D; Evangelisti, C; Ricci, F; Tabellini, G; Chiarini, F; Tazzari, Pl; Melchionda, F; Buontempo, F; Pagliaro, P; Pession, A; Mccubrey, Ja; Martelli, Am
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance.
2012 McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Franklin RA; Montalto G; Cervello M; Libra M; Candido S; Malaponte G; Mazzarino MC; Fagone P; Nicoletti F; Bäsecke J; Mijatovic S; MaksimovicIvanic D; Milella M; Tafuri A; Chiarini F; Evangelisti C; Cocco L; Martelli AM.
Targeting the cancer initiating cell: The ultimate target for cancer therapy
2012 Mccubrey, Ja; Steelman, Ls; Abrams, Sl; Misaghian, N; Chappell, Wh; Basecke, J; Nicoletti, F; Libra, M; Ligresti, G; Stivala, F; Maksimovicivanic, D; Mijatovic, S; Montalto, G; Cervello, M; Laidler, P; Bonati, A; Evangelisti, C; Cocco, L; Martelli, Am
The emerging multiple roles of nuclear Akt.
2012 Martelli AM; Tabellini G; Bressanin D; Ognibene A; Goto K; Cocco L; Evangelisti C.
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.
2012 Martelli AM; Chiarini F; Evangelisti C; Cappellini A; Buontempo F; Bressanin D; Fini M; McCubrey JA.
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity.
2011 Steelman, Ls; Martelli, Am; Nicoletti, F; Mccubrey, Ja
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.
2011 Steelman LS; Navolanic P; Chappell WH; Abrams SL; Wong EW; Martelli AM; Cocco L; Stivala F; Libra M; Nicoletti F; Drobot LB; Franklin RA; McCubrey JA.
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy
2011 Sokolosky, Ml; Stadelman, Km; Chappell, Wh; Abrams, Sl; Martelli, Am; Stivala, F; Libra, M; Nicoletti, F; Drobot, Lb; Franklin, Ra; Steelman, Ls; Mccubrey, Ja
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress.
2011 Blalock, Wl; Bavelloni, A; Piazzi, M; Tagliavini, F; Faenza, I; Martelli, Am; Follo, My; Cocco, L
Nuclear phosphoinositides and their roles in cell biology and disease.
2011 Martelli, Am; Ognibene, A; Buontempo, F; Fini, M; Bressanin, D; Goto, K; Mccubrey, Ja; Cocco, L; Evangelisti, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH | 1-gen-2024 | Cervello, Melchiorre; Augello, Giuseppa; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y.; Martelli, Alberto M.; Cusimano, Antonella; Montalto, Giuseppe; Mccubrey, James A. | |
| Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy | 1-gen-2016 | Candido, S; Abrams, Sl; Steelman, Ls; Lertpiriyapong, K; Fitzgerald, Tl; Martelli, Am; Cocco, L; Montalto, G; Cervello, M; Polesel, J; Libra, M; Mccubrey, Ja | |
| Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment | 1-gen-2013 | Chappell, Wh; Abrams, Sl; Stadelman, Km; Lahair, Mm; Franklin, Ra; Cocco, L; Evangelisti, C; Chiarini, F; Martelli, Am; Steelman, Ls; Mccubrey, Ja | |
| The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy | 1-gen-2013 | Simioni, C; Martelli, Am; Cani, A; Cetinatalay, R; Mccubrey, Ja; Capitani, S; Neri, Lm | |
| Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients. | 1-gen-2012 | Follo, My; Mongiorgi, S; Clissa, C; Paolini, S; Martinelli, G; Martelli, Am; Fioravanti, G; Manzoli, L; Finelli, C; Cocco, L | |
| Activity of the selective I?B kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a. | 1-gen-2012 | Buontempo F; Chiarini F; Bressanin D; Tabellini G; Melchionda F; Pession A; Fini M; Neri LM; McCubrey JA; Martelli AM. | |
| AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. | 1-gen-2012 | Grimaldi C; Chiarini F; Tabellini G; Ricci F; Tazzari PL; Battistelli M; Falcieri E; Bortul R; Melchionda F; Iacobucci I; Pagliaro P; Martinelli G; Pession A; Barata JT; McCubrey JA; Martelli AM. | |
| Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. | 1-gen-2012 | Simioni, C; Neri, Lm; Tabellini, G; Ricci, F; Bressanin, D; Chiarini, F; Evangelisti, C; Cani, A; Tazzari, Pl; Melchionda, F; Pagliaro, P; Pession, A; Mccubrey, Ja; Capitani, S; Martelli, Am | |
| Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine. | 1-gen-2012 | Chappell, Wh; Abrams, Sl; Franklin, Ra; Lahair, Mm; Montalto, G; Cervello, M; Martelli, Am; Nicoletti, F; Candido, S; Libra, M; Polesel, J; Talamini, R; Milella, M; Tafuri, A; Steelman, Ls; Mccubrey, Ja | |
| Effects of ectopic expression of NGAL on doxorubicin sensitivity | 1-gen-2012 | Chappell, Wh; Abrams, Sl; Montalto, G; Cervello, M; Martelli, Am; Candido, S; Libra, M; Polesel, J; Talamini, R; Arlinghaus, R; Steelman, Ls; Mccubrey, Ja | |
| Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. | 1-gen-2012 | Bressanin, D; Evangelisti, C; Ricci, F; Tabellini, G; Chiarini, F; Tazzari, Pl; Melchionda, F; Buontempo, F; Pagliaro, P; Pession, A; Mccubrey, Ja; Martelli, Am | |
| Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. | 1-gen-2012 | McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Franklin RA; Montalto G; Cervello M; Libra M; Candido S; Malaponte G; Mazzarino MC; Fagone P; Nicoletti F; Bäsecke J; Mijatovic S; MaksimovicIvanic D; Milella M; Tafuri A; Chiarini F; Evangelisti C; Cocco L; Martelli AM. | |
| Targeting the cancer initiating cell: The ultimate target for cancer therapy | 1-gen-2012 | Mccubrey, Ja; Steelman, Ls; Abrams, Sl; Misaghian, N; Chappell, Wh; Basecke, J; Nicoletti, F; Libra, M; Ligresti, G; Stivala, F; Maksimovicivanic, D; Mijatovic, S; Montalto, G; Cervello, M; Laidler, P; Bonati, A; Evangelisti, C; Cocco, L; Martelli, Am | |
| The emerging multiple roles of nuclear Akt. | 1-gen-2012 | Martelli AM; Tabellini G; Bressanin D; Ognibene A; Goto K; Cocco L; Evangelisti C. | |
| Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. | 1-gen-2012 | Martelli AM; Chiarini F; Evangelisti C; Cappellini A; Buontempo F; Bressanin D; Fini M; McCubrey JA. | |
| Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. | 1-gen-2011 | Steelman, Ls; Martelli, Am; Nicoletti, F; Mccubrey, Ja | |
| Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. | 1-gen-2011 | Steelman LS; Navolanic P; Chappell WH; Abrams SL; Wong EW; Martelli AM; Cocco L; Stivala F; Libra M; Nicoletti F; Drobot LB; Franklin RA; McCubrey JA. | |
| Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy | 1-gen-2011 | Sokolosky, Ml; Stadelman, Km; Chappell, Wh; Abrams, Sl; Martelli, Am; Stivala, F; Libra, M; Nicoletti, F; Drobot, Lb; Franklin, Ra; Steelman, Ls; Mccubrey, Ja | |
| Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. | 1-gen-2011 | Blalock, Wl; Bavelloni, A; Piazzi, M; Tagliavini, F; Faenza, I; Martelli, Am; Follo, My; Cocco, L | |
| Nuclear phosphoinositides and their roles in cell biology and disease. | 1-gen-2011 | Martelli, Am; Ognibene, A; Buontempo, F; Fini, M; Bressanin, D; Goto, K; Mccubrey, Ja; Cocco, L; Evangelisti, C |